C.J.M. Melief

1.5k total citations
16 papers, 951 citations indexed

About

C.J.M. Melief is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, C.J.M. Melief has authored 16 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in C.J.M. Melief's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). C.J.M. Melief is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). C.J.M. Melief collaborates with scholars based in Netherlands, United States and Germany. C.J.M. Melief's co-authors include René E. M. Toes, Rienk Offringa, W. Martin Kast, R. Blom, Jürgen Kuball, Hans J. Stauss, Carina Lotz, Ralph A. Willemsen, Thomas Ruppert and Elena Sadovnikova and has published in prestigious journals such as The Journal of Experimental Medicine, Nature Immunology and The Journal of Immunology.

In The Last Decade

C.J.M. Melief

16 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.J.M. Melief Netherlands	11	732	405	289	158	108	16	951
Cees J. M. Melief Netherlands	9	801 1.1×	322 0.8×	472 1.6×	108 0.7×	81 0.8×	11	1.3k
Franco Marincola United States	14	1.1k 1.4×	627 1.5×	385 1.3×	96 0.6×	156 1.4×	20	1.3k
J Biggs United States	13	902 1.2×	412 1.0×	299 1.0×	150 0.9×	81 0.8×	17	1.0k
R J Armitage Canada	8	835 1.1×	325 0.8×	202 0.7×	61 0.4×	137 1.3×	8	1.1k
H. Robson MacDonald Switzerland	16	941 1.3×	225 0.6×	150 0.5×	108 0.7×	54 0.5×	30	1.1k
Lynn J. Buchanan United Kingdom	4	532 0.7×	420 1.0×	189 0.7×	178 1.1×	47 0.4×	7	801
Dania Caron United States	16	1.3k 1.8×	454 1.1×	319 1.1×	60 0.4×	58 0.5×	21	1.5k
Wayne Aldrich United States	19	590 0.8×	419 1.0×	501 1.7×	262 1.7×	50 0.5×	46	1.1k
Tamás Schweighoffer Austria	15	599 0.8×	207 0.5×	314 1.1×	134 0.8×	44 0.4×	30	952
Sonja Van Meirvenne Belgium	15	707 1.0×	345 0.9×	516 1.8×	215 1.4×	49 0.5×	19	1.0k

Countries citing papers authored by C.J.M. Melief

Since Specialization

Citations

This map shows the geographic impact of C.J.M. Melief's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J.M. Melief with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J.M. Melief more than expected).

Fields of papers citing papers by C.J.M. Melief

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J.M. Melief. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J.M. Melief. The network helps show where C.J.M. Melief may publish in the future.

Co-authorship network of co-authors of C.J.M. Melief

This figure shows the co-authorship network connecting the top 25 collaborators of C.J.M. Melief. A scholar is included among the top collaborators of C.J.M. Melief based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J.M. Melief. C.J.M. Melief is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Glisson, Bonnie S., Erminia Massarelli, William N. William, et al.. (2017). Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer. Annals of Oncology. 28. v403–v404. 17 indexed citations

Nijman, Hans W., C.J.M. Melief, Toos Daemen, & Ninke Leffers. (2009). 228 Antigen specific active immunotherapy for ovarian cancer. European Journal of Cancer Supplements. 7(2). 57–58. 2 indexed citations

Ossevoort, Miriam A., Diana J.M. van den Wollenberg, Ellen I. H. van der Voort, et al.. (2003). Creation of immune ‘stealth’ genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1. Gene Therapy. 10(24). 2020–2028. 27 indexed citations

Ugolini, Sophie, Christophe Arpin, Nicolas Anfossi, et al.. (2001). Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nature Immunology. 2(5). 430–435. 137 indexed citations

Lotz, Carina, Elena Sadovnikova, Ralph A. Willemsen, et al.. (2001). Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nature Immunology. 2(10). 962–970. 297 indexed citations

Burg, Sjoerd H. van der, Michèl R. Klein, Oscar Pontesilli, et al.. (1997). HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS. The Journal of Immunology. 159(7). 3648–3654. 22 indexed citations

Medema, Jan Paul, René E. M. Toes, Carsten Scaffidi, et al.. (1997). Cleavage of FLICE (caspase‐8) by granzyme B during cytotoxic T lymphocyte‐induced apoptosis. European Journal of Immunology. 27(12). 3492–3498. 126 indexed citations

Toes, René E. M., R. Blom, Rienk Offringa, W. Martin Kast, & C.J.M. Melief. (1996). Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. The Journal of Immunology. 156(10). 3911–3918. 174 indexed citations

Claësson, Mogens H., Arne Svejgaard, Sjoerd H. van der Burg, et al.. (1996). clone recognizing a wild-type p53-derived peptide Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte. Leiden Repository (Leiden University). 93. 14704–14707. 10 indexed citations

10.

Twuyver, E. van, et al.. (1989). Transfusion-induced skin allograft enhancement across an H-2 class-I mismatch is caused by a clonal deletion of donor-specific cytotoxic T-lymphocyte precursors within the allograft.. PubMed. 21(1 Pt 1). 1169–70. 3 indexed citations

11.

Melief, C.J.M.. (1983). Remodelling the H-2 map. Immunology Today. 4(3). 57–58. 8 indexed citations

12.

Townsend, Alain, Patricia M. Taylor, C.J.M. Melief, & Brigitte A. Askonas. (1983). Diversity in the interaction of influenza-A-specific cytotoxic T cells with H-2Kb mutant targets. Immunogenetics. 17(5). 543–549. 5 indexed citations

13.

Stukart, M J, et al.. (1982). A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.. The Journal of Immunology. 128(3). 1360–1364. 33 indexed citations

14.

Melief, C.J.M., et al.. (1980). Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutants.. The Journal of Experimental Medicine. 151(5). 993–1013. 75 indexed citations

15.

Melief, C.J.M., et al.. (1979). Target specificity of cytotoxic t cells directed against h-2l. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 324. 1 indexed citations

16.

Datta, Syamal K., et al.. (1978). Genetic differences unrelated toH-2 inH-2 congenic mice. Immunogenetics. 7(1). 359–365. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact